Research graph
References from Risk of psoriasis in patients treated with dupilumab for bullous pemphigoid: A cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
Development of psoriasis during treatment with dupilumab: a systematic review
10.1016/j.jaad.2021.05.013 · 2022 · External reference
Psoriasis risk in patients with atopic dermatitis treated with dupilumab
10.1001/jamadermatol.2025.1578 · 2025 · External reference
Evaluation of dupilumab in patients with bullous pemphigoid
10.1001/jamadermatol.2023.2428 · 2023 · External reference
10.1111/ddg.70397
10.1111/ddg.70397 · External reference
Dupilumab for bullous pemphigoid: umbrella review of systematic reviews and meta‐analyses
10.1016/j.jdin.2025.10.004 · 2025 · External reference
Evaluation of dupilumab in patients with bullous pemphigoid
10.1001/jamadermatol.2023.2428 · ExternalCitation · doi-reference
Psoriasis risk in patients with atopic dermatitis treated with dupilumab
10.1001/jamadermatol.2025.1578 · ExternalCitation · doi-reference
Development of psoriasis during treatment with dupilumab: a systematic review
10.1016/j.jaad.2021.05.013 · ExternalCitation · doi-reference
Dupilumab for bullous pemphigoid: umbrella review of systematic reviews and meta‐analyses
10.1016/j.jdin.2025.10.004 · ExternalCitation · doi-reference
10.1111/ddg.70397
10.1111/ddg.70397 · ExternalCitation · doi-reference
